Back to today’s briefing

Story perspectives

CMS Raises Concerns Over Puberty Blockers Amid Policy Changes

3/7/2025

33 4

Summary

Story summary

The Centers for Medicare & Medicaid Services (CMS) has raised alarms over puberty blockers, deeming them "harmful" and hinting at possible policy changes. This comes on the heels of a court ruling that overturned funding cuts for gender-affirming care. With around 300,000 U.S. youths identifying as transgender, the stakes are high, as studies show these blockers can significantly lower suicide rates.

1 of 1

Story summary

The Centers for Medicare & Medicaid Services (CMS) has raised alarms over puberty blockers, deeming them "harmful" and hinting at possible policy changes. This comes on the heels of a court ruling that overturned funding cuts for gender-affirming care. With around 300,000 U.S. youths identifying as transgender, the stakes are high, as studies show these blockers can significantly lower suicide rates.